The Use of Galantamine (Reminyl ER) in Patients With MIXed Dementia: Effects on Cognition and Quality of Life
Clinical trial NCT00814658 · COMPLETED
Trial details
- NCT number
- NCT00814658
- Sponsor
- Janssen-Cilag Farmaceutica Ltda.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2009-10-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.